Press "Enter" to skip to content

New patent for Pharmacyclics Inc drug IMBRUVICA

0
Copyright © DrugPatentWatch. Originally published at New patent for Pharmacyclics Inc drug IMBRUVICA

Annual Drug Patent Expirations for IMBRUVICA
Annual Drug Patent Expirations for IMBRUVICA

Imbruvica is a drug marketed by Pharmacyclics Inc and is included in two NDAs. It is available from one supplier. There are twenty-four patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for IMBRUVICA.

This drug has one hundred and ninety-eight patent family members in thirty-eight countries.

The generic ingredient in IMBRUVICA is ibrutinib. One supplier is listed for this compound. Additional details are available on the ibrutinib profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for Pharmacyclics Inc drug IMBRUVICA
Do NOT follow this link or you will be banned from the site!